Facebook Instagram Linkedin Youtube
Home Tags Abliva

Tag: Abliva

Abliva MitochondrialDiseaseWeek 2024

Abliva leads the fight against mitochondrial disease

Ablivas CEO: "We remain on track for the interim analysis early in Q3"

Ablivas CEO: “We remain on track for the interim analysis early...

Dag Nesse, VP of Clinical Operations Abliva mot en grön bakgrund

Abliva’s VP of Clinical Operations on the screening achievement

Mitochondrial Disease Awareness Week

Abliva increases awareness of mitochondrial diseases

Abliva’s CEO: “One step closer to a marketed medicine”

Abliva receives FDA Fast Track designation

CombiGene focuses on the pain project

First patient dosed in Abliva’s Falcon study

Abliva’s CEO: “One step closer to a marketed medicine”

Abliva’s CEO about the phase II study

BioStock Investor Meeting starts today at 10.00

BioStock Investor Meeting starts today at 10.00

Dag Nesse, VP of Clinical Operations Abliva mot en grön bakgrund

Abliva recruits Vice President of Clinical Operations

Abliva starts late-stage study with KL1333

12Page 1 of 2
© BioStock 2024